首頁 › 大腸直腸癌 › 德克薩斯州 › Fort Worth
Fort Worth, TX 的 大腸直腸癌 臨床試驗
7 項針對 大腸直腸癌 的研究正在 Fort Worth(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
招募中2 期
- START Dallas Fort Worth, Fort Worth
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- START Center for Clinical Research, Fort Worth
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
招募中3 期
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
招募中3 期
- Clinical Study Site, Fort Worth
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
招募中2 期
- The Center For Cancer And Blood Disorders /ID# 278512, Fort Worth
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- START Dallas Fort Worth, LLC, Fort Worth
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
招募中1 期
- START Dallas Fort Worth, LLC, Fort Worth
其他城市的 大腸直腸癌 試驗
- Houston, TX102 項研究
- New York City, NY78 項研究
- Nashville, TN69 項研究
- Boston, MA63 項研究
- Los Angeles, CA59 項研究
- Arlington, VA52 項研究
- St. Louis, MO50 項研究
- San Antonio, TX46 項研究
- Philadelphia, PA44 項研究
- Grand Rapids, MI40 項研究
- Baldwin Park, CA37 項研究
- Chicago, IL34 項研究
Fort Worth 的其他研究
- 非小細胞肺癌18 項研究
- 卵巢癌17 項研究
- 子宮內膜癌12 項研究
- 乳癌12 項研究
- 癌症(所有類型)9 項研究
- 前列腺癌9 項研究
- 三陰性乳癌7 項研究
- 黃斑部病變7 項研究
- 潰瘍性結腸炎7 項研究
- 腎臟癌(腎細胞癌)7 項研究
- 心臟衰竭7 項研究
- 轉移性癌症7 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。